<b>Conclusions:</b> These findings characterize a <i>BAG3</i>-associated TAM program with spatial, immunoregulatory, and prognostic relevance in HCC, and support its further evaluation in biomarker and mechanistic studies. The gene discussed is BAG3; the disease is hepatocellular carcinoma.